Eaton Vance Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.69M | Buy |
6,452
+104
| +2% | +$43.4K | ﹤0.01% | 958 |
|
|
2022
Q2 | $3.14M | Sell |
6,348
-6,038
| -49% | -$2.99M | ﹤0.01% | 936 |
|
|
2022
Q1 | $6.98M | Buy |
12,386
+9,794
| +378% | +$5.52M | 0.01% | 795 |
|
|
2021
Q4 | $1.96M | Buy |
2,592
+129
| +5% | +$97.4K | ﹤0.01% | 1029 |
|
|
2021
Q3 | $1.16M | Buy |
2,463
+1,249
| +103% | +$586K | ﹤0.01% | 1059 |
|
|
2021
Q2 | $781K | Buy |
1,214
+1,023
| +536% | +$658K | ﹤0.01% | 1241 |
|
|
2021
Q1 | $109K | Buy |
+191
| New | +$109K | ﹤0.01% | 1583 |
|